LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

Generic Information: LuciAvat (Avatrombopag) — Lucius Pharmaceuticals, Laos

LuciAvat is the avatrombopag film-coated tablet of Lucius Pharmaceuticals (Lao) Co., Ltd., based at No. 26 Thongmang village, Xaythany district, Vientiane Capital. Each box holds 28 tablets at 20 mg, and the insert spells out a detail careful buyers appreciate: every tablet contains 23.6 mg of avatrombopag maleate, equivalent to 20 mg of avatrombopag base — the salt-to-base conversion printed openly, exactly as reference labeling does it. Lucius runs one of Laos's most recognized export brands, its "Luci-" family spanning oncology and hepatology staples that GLT has shipped for years.

What Is LuciAvat Used For?

The Lao registration carries both reference indications: thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure, and chronic immune thrombocytopenia in adults with insufficient response to prior therapy. The 28-tablet box aligns with a full month of once-daily ITP dosing, and for the CLD bridge it leaves a margin above the 10–15 tablets a five-day course consumes — useful when a physician schedules a count re-check or a repeat procedure. The insert also prints the boundary every liver patient should know: this medicine serves the procedure window, not everyday count chasing.

How Does LuciAvat Work?

The active molecule engages the thrombopoietin receptor — c-Mpl — on megakaryocyte progenitors at the transmembrane region, a second-generation binding mode that runs additive with the body's own TPO rather than fighting it for the binding site. Platelet counts climb from day three to five and crest near day ten to thirteen. With no chelating chemistry, the tablet tolerates ordinary meals, dairy and antacids — no empty-stomach window — which keeps pre-surgical schedules simple for patients already managing encephalopathy diets, diuretics and antivirals.

Indications of LuciAvat (Laos)

The Lao insert reads directly: indicated for thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure, and thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to previous treatment. Retail of the product in Laos is restricted to prescription channels under a registered oncologist's direction — a line Lucius prints on the carton itself, and one GLT honors by requesting the treating physician's prescription with every order.

Dosage and Administration

Swallow tablets whole with food — never split or chewed. For the CLD course: begin ten to thirteen days before the procedure; below 40×10⁹/L platelets take 60 mg (three tablets) once daily for five days; from 40 to below 50×10⁹/L take 40 mg (two tablets) once daily for five days; undergo the procedure five to eight days after the last dose. For chronic ITP: start at 20 mg (one tablet) daily and titrate to keep counts at or above 50×10⁹/L, never exceeding 40 mg daily, with weekly early blood checks. A missed dose is taken when remembered, with food; doubling is never allowed.

Side Effects of LuciAvat

The documented profile matches the class: in liver-disease patients, fever, abdominal pain, nausea, headache, fatigue and peripheral swelling; in ITP patients, headache, tiredness, bruising, nosebleeds, gum bleeding, joint pain, pinpoint petechiae and respiratory tract infections. The highlighted serious risk is thrombosis from platelet overshoot — counts are monitored, doses stepped down at high readings, and warning symptoms (chest pain, breathlessness, painful swollen leg, severe headache) treated as emergencies.

Storage Instructions

Store at 20–25°C, short excursions between 15–30°C permitted, in the original box away from light and moisture. No refrigeration. Keep out of children's reach; return unused tablets to a pharmacy for disposal.

Why Choose LuciAvat from GLT?

LuciAvat balances three things buyers actually weigh: a transparent insert with the maleate conversion printed (no hidden salt math), a 28-count pack that fits chronic dosing, and a Lao manufacturing address with a decade of GLT shipping history behind it. Typical landed cost for a Lucius box sits far below originator channels — often quoted around the level of a restaurant meal for a month of ITP therapy — and GLT documents every lot with pre-shipment photographs, CoA on request and full export papers. The team answers directly on WhatsApp +86 15234153837 or [email protected].

How to Order LuciAvat (Avatrombopag)

Message WhatsApp +86 15234153837 or email [email protected] with the number of boxes and your country. GLT returns a formal quotation with courier and payment options — typically within one working day — and ships sealed cartons with complete documentation on confirmation. Monthly resupply for ongoing ITP can be scheduled automatically.

FAQ

Why does the insert say 23.6 mg? That is the maleate salt amount; it delivers exactly 20 mg of avatrombopag base — the same convention the originator uses, now printed openly on the Lao insert.

Who is Lucius Pharmaceuticals? A Vientiane-based Lao manufacturer whose Luci- product family exports across Asia, the Middle East and beyond; LuciAvat is its avatrombopag brand.

How does LuciAvat compare with the Bangladeshi options? Same 20 mg molecule; the practical differences are pack price, box size and shipping lane — GLT quotes all side by side so the choice is numeric.

Is a prescription required? Yes — the carton itself restricts retail to prescription of a registered physician; GLT asks for your doctor's prescription or medical summary with the order.

What if a dose is taken without food? Take it as soon as possible with a meal; absorption is better with food, and from the next dose keep the with-meal habit — no compensation or doubling.